Immune Design reports fourth quarter and full year 2014 financial results
Immune Design reported full year 2014 net loss was $34.2 million, or $4.56 per basic and diluted share, versus a full year 2013 net loss of $16.0 million, or $43.48 per basic and diluted share. Revenue for the full year 2014 was $6.4 million in 2014 versus $1.6 million in 2013. March 31, 2015